Welcome to our dedicated page for Oxford Square Capital SEC filings (Ticker: OXSQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oxford Square Capital Corp. filings document regulatory disclosures for a closed-end, non-diversified management investment company focused on corporate debt securities and CLO structured finance investments. Form 8-K reports furnish quarterly and fiscal-year results, including net asset value, net investment income and press-release exhibits, and report material events such as amendments to equity distribution arrangements under an effective Form N-2 shelf registration statement.
The filing record also covers capital structure and governance matters, including Nasdaq-listed common stock, 5.50% Notes due 2028, 7.75% Notes due 2030, charter amendments affecting authorized capital stock, and Form 25 delisting and registration-withdrawal records for a prior notes class.
Oxford Square Capital Corp. (OXSQ) reports that its Annual Meeting of Stockholders was held on August 20, 2026, with a quorum present. A total of 105,058,242 shares of common stock were entitled to vote as of the June 30, 2026 record date.
Stockholders elected Steven P. Novak and Charles M. Royce as directors for three-year terms expiring at the 2029 annual meeting. Stockholders also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Oxford Square Capital Corp., a Maryland-based investment company, reported total assets of $290.6 million and net assets of $135.0 million as of June 30 2026, compared with $306.7 million and $145.4 million at December 31 2025. Net asset value per common share was $1.29 versus $1.69.
The portfolio is concentrated in income-producing credit strategies. Investments at cost totaled $386.4 million with a fair value of $252.8 million. Senior secured notes had a fair value of $147.2 million (109.0% of net assets), and collateralized loan obligation (CLO) equity investments had a fair value of $90.3 million (66.9% of net assets). Equity and other investments totaled $15.4 million (11.4% of net assets).
Liabilities were driven by two unsecured note issuances with carrying amounts of $79.7 million (5.50% notes) and $72.4 million (7.75% notes). The company held $32.8 million in cash equivalents and 105,058,242 common shares were outstanding as of June 30 2026; 107,707,775 shares were outstanding as of August 7 2026.
Oxford Square Capital Corp. reported results for the quarter ended June 30, 2026 and declared three monthly common stock distributions of $0.035 per share for October, November and December 2026.
For the second quarter 2026, total investment income was $9.4 million compared with $9.5 million a year earlier. Net investment income was $5.1 million, or $0.05 per share, versus $5.5 million, or $0.08 per share, in the prior-year quarter. After unrealized gains of $4.1 million and realized losses of $5.2 million, net increase in net assets from operations was $4.0 million versus $4.4 million a year earlier.
As of June 30, 2026, total assets were $290.6 million and net assets were $135.0 million. Net asset value per share was $1.29, down from $1.69 at December 31, 2025. For the quarter, total return based on net asset value was 5.68%, while total return based on market value was (19.75)%.
Oxford Square Capital Corp. reported second-quarter 2026 results and declared monthly common stock distributions of $0.035 per share for the months ending October 31, November 30, and December 31, 2026, with record dates of October 16, November 16, and December 17, respectively.
For the quarter ended June 30, 2026, total investment income was $9.4 million and net investment income was $5.1 million, or $0.05 per share. Net assets were $135.0 million, or $1.29 net asset value per share, based on 105,058,242 shares outstanding.
Net realized losses on investments for the first six months of 2026 were $35.95 million, partly offset by unrealized gains, leading to a six-month net decrease in net assets from operations of $21.53 million. Second-quarter total return based on net asset value was 5.68%, while total return based on market value was -19.75%.
Oxford Square Capital Corp. is soliciting proxies for its 2026 annual meeting to elect two directors and ratify Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026. The meeting is scheduled for August 20, 2026, at the company’s Greenwich, Connecticut headquarters.
Stockholders of record as of June 30, 2026 may vote, with 105,058,242 common shares outstanding, each entitled to one vote. The board, including all independent directors, unanimously recommends voting “FOR” the election of Steven P. Novak and Charles M. Royce and “FOR” ratifying Ernst & Young. PricewaterhouseCoopers was dismissed as auditor in May 2026, with no reported disagreements or reportable events, and audit fees for 2025 totaled $1,015,576.
Oxford Square Capital Corp. has changed its independent auditor, dismissing PricewaterhouseCoopers LLP and appointing Ernst & Young LLP. The board of directors approved this move based on the audit committee’s recommendation.
PWC’s audit reports on the company’s financial statements for the years ended December 31, 2025 and 2024 contained no adverse opinions, disclaimers, or qualifications. The company states there were no disagreements with PwC on accounting, disclosure, or audit scope, and no reportable events during those periods. PwC provided a confirming letter to the SEC, which is attached as an exhibit.
Oxford Square Capital Corp. President and COO Saul B. Rosenthal bought shares of the company in the open market. On May 20, 2026, he purchased 144,703 shares of common stock at a weighted average price of $1.1517 per share in an open-market transaction.
The purchased shares were acquired into a joint tenants in common account in which Rosenthal has a 50% pecuniary interest, with CEO Jonathan H. Cohen holding the other 50%. After this transaction, Rosenthal directly owned 2,201,479 common shares and indirectly held 1,898 shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.
Oxford Square Capital Corp. Chief Executive Officer Jonathan H. Cohen reported an open-market purchase of 144,704 shares of common stock at a weighted average price of $1.1517 per share on May 20, 2026. The shares were bought into a joint tenants in common account in which Cohen has a 50% pecuniary interest and President and COO Saul B. Rosenthal holds the other 50%. Following this transaction, Cohen directly owns 2,417,193 common shares and indirectly holds 1,898 additional shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.
Oxford Square Capital Corp. amended its charter to expand its flexibility to issue stock in the future. The company increased its total authorized capital stock from 100,000,000 shares to 300,000,000 shares, all designated as common stock with a par value of $0.01 per share. The Articles of Amendment were filed with the Maryland State Department of Assessments and Taxation and became effective immediately upon filing.
Oxford Square Capital Corp. filed an 8-K describing amendment no. 1 to its amended and restated equity distribution agreement with Oxford Square Management, Oxford Funds, Lucid Capital Markets and Ladenburg Thalmann as sales agents. The amendment allows sales of common stock to continue under the company’s effective Form N-2 shelf registration statement, supported by a new prospectus supplement dated May 5, 2026.
The company also filed a legality opinion from Dechert LLP covering shares to be sold pursuant to the amended equity distribution agreement, together with related consent and technical XBRL exhibit items.